Xarelto Lawsuit Claims Drug Caused Death Of Vermont Man

November 30, 2015 – – BloodThinnerHelp.com reports on another Xarelto lawsuit which was filed against the drug’s manufactureres in connection with the death of a Vermont man. The case, number 2:14-cv-00159-CR ,was filed by the daughter of the deceased in a Vermont federal court. Allegations within her suit claim that the uncontrollable bleeding, which led to her father’s death, was caused by the blood thinner Xarelto.

Details further explaining this case state that the plaintiff’s father was prescribed Xarelto to treat his atrial fibrillation condition. Atrial fibrillation can cause complications such as blood clots and strokes, so blood thinners are commonly prescribed to individuals with this condition in order to prevent these occurrences. After using Xarelto just a short time, the man became injured and started to bleed. He was hospitalized at this time, as physicians diagnosed him with a parenchymal hemorrhage. The medical staff was unable to stop the man’s bleeding due to the fact that he still had active Xarelto in his system. They tried to keep the man alive, which they managed to for just 6 days before he ultimately passed away due to blood loss.

In her complaint, the plaintiff indicates that she and her father had never been made aware of one of the most dangerous aspects of Xarelto: the drug has no corresponding antidote. Because of this, when someone taking the drug begins to bleed, physicians cannot counter the effects and get their blood to clot. In these cases, doctors must resort to life-saving measures such as blood transfusions in an attempt to save the individual’s life. More traditional blood thinners offer the antidote of vitamin K. If someone using a traditional blood thinner begins to bleed, doctors can treat them with vitamin K, which counters the medicine’s effects and allows their blood to clot. For this reason, Xarelto is considered by many to be the most dangerous blood thinner on the market.

This lawsuit was filed against manufacturers Janssen Pharmaceuticals (a division of Johnson & Johnson), and Bayer AG. It alleges that they were reckless and negligent by marketing a drug for which there was no corresponding antidote, and which poses so many uncontrollable bleeding dangers.

At this time, Xarelto lawsuits have surged to number over 1,700 cases in federal court, which have been consolidated to form multidistrict litigation number 2592. As these cases await trial, it is expected that others will be filed. Attorney Joseph Osborne is working to ensure that anyone who has been affected by adverse health effects associated with the drug has the opportunity to explore their legal rights in the matter. These individuals may be entitled to significant compensation. Attorney Osborne is currently offering free legal consultations to those involved.

To obtain additional information on Xarelto lawsuits, or to ask questions, please contact Joseph Osborne, Esq. by calling (866) 425-8902.

###

Contact BloodThinnerHelp.com:

Joseph Osborne
866-425-8902
Mizner Park
433 Plaza Real Blvd., Ste. 271
Boca Raton, FL 33432

ReleaseID: 60005878